RxDoctor Payments Data

Anthony Casamo, PA

Medical · Franklin, TNNPI 1538148861

Payments from drug & device makers

$699in general payments, 2019–2025

Across 22 payments — averaging $31.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$224
  • AbbVie$132
  • Johnson & Johnson$77
  • Pfizer$42
  • Novo Nordisk$38
  • Teva Pharmaceuticals USA, Inc.$34
  • plus $153 from 7 others

What the payments were for

  • Food & beverage$62289%
  • Education$7711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$699 in reported general payments places this provider in the 55th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Medicare billing

Part B allowed, 2024
$37,947
Medicare patients
243
Services billed
395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gamunex-CImmune Globul G/Gly/Iga Avg 4655$487,922
IngrezzaValbenazine Tosylate23$176,037
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5012$90,354
Aimovig AutoinjectorErenumab-Aooe39$49,941
MysolinePrimidone20$38,095
VimpatLacosamide23$37,214
QuliptaAtogepant23$24,028
Levetiracetam263$11,420
Emgality PenGalcanezumab-Gnlm14$10,741
Carbamazepine ErCarbamazepine35$8,321
Tiagabine Hcl12$7,822
Carbidopa-LevodopaCarbidopa/Levodopa209$6,376
Memantine Hcl218$5,833
Diazepam18$5,751
Gabapentin302$5,331

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$32$176,03723 claims
AbbVieQulipta$132$24,02823 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 480 medical providers in Tennessee.

Other medical in Franklin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →